Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Outcomes for children with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) are
dismal. Therefore, the investigators performed this multicenter, phase II study to evaluate
the efficacy and , safety and pharmacokinetic of clofarabine in Chinese pediatric patients
with R/R ALL